NextCure, Inc.
NXTC
$0.3348
$0.00210.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.62% | -8.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.32% | -24.25% | |||
| Operating Income | 0.32% | 24.25% | |||
| Income Before Tax | -0.55% | 25.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.55% | 25.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.55% | 25.08% | |||
| EBIT | 0.32% | 24.25% | |||
| EBITDA | 0.12% | 25.32% | |||
| EPS Basic | -0.44% | 25.10% | |||
| Normalized Basic EPS | -0.43% | 25.10% | |||
| EPS Diluted | -0.44% | 25.10% | |||
| Normalized Diluted EPS | -0.43% | 25.10% | |||
| Average Basic Shares Outstanding | 0.11% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||